<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <funding-statement>DMS acknowledges funding support from the Pacific Southwest Regional Center of Excellence for Vector-Borne Diseases funded by the U.S. Centers for Disease Control and Prevention (CDC, Cooperative Agreement 1U01CK000516). CBFV is supported by NWO Rubicon 019.181EN.004. KGA is a Pew Biomedical Scholar, and is supported by NIH NCATS CTSA UL1TR002550, NIAID contract HHSN272201400048C, NIAID R21AI137690, NIAID U19AI135995, and The Ray Thomas Foundation. RCS and RET are supported in part by the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) Program Components Contract 5887EL11 through the Iowa Department of Public Health and the Midwest Center of Excellence for Vector-Borne Diseases by Cooperative Agreement U01CK000505, funded by the CDC. TB is a Pew Biomedical Scholar. TB and JH are supported by NIH R35 GM119774-01. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or the Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
